New Analysis adds to evidence collected on pneumonia risk

A recent analysis of a major trial highlighted the risk in COPD patients citing a link between increased risks of pneumonia and inhaled steroid therapy.
According to the first detailed analysis of safety data obtained from the influential TORCH study, there is a risk of pneumonia with inhaled steroid therapy by as much as 50 percent. [...]